跳至主要内容
临床试验/ACTRN12622000314729
ACTRN12622000314729尚未招募1 期

Assessing dissemination and feasibility of the Implementation of a new model of care, in the community, for women with moderate to severe nausea or vomiting of pregnancy.

Women's Health Initiative Translation Unit (WHITU)0 个研究点目标入组 150 人开始时间: 2022年2月21日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
Female

入选标准

  • Pregnant with moderate to severe nausea or vomiting of pregnancy (PUQE-24 score of equal to or greater than 7).

排除标准

  • Not pregnant
  • Unwilling or unable to receive IVT at home
  • Patients with a condition that interferes with their ability to understand the study’s requirements.
  • Patients with an underlying health condition including Type 1 diabetes, renal or cardiac disease, epilepsy, short bowel syndrome or bariatric surgery that is likely to interfere with the evaluation of patient safety or the study outcome.
  • Severe electrolyte disturbance or a creatinine of >90umol/L
  • Other diagnosis that is contributing to NVPHG: thyrotoxicosis

研究者

发起方
Women's Health Initiative Translation Unit (WHITU)

相似试验

Receiving, Intravenous fluids for Moderate to Severe... | 临床试验